|Deltex Medical Group
||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Deltex Medical Share Discussion Threads
Showing 18676 to 18699 of 18700 messages
|???Lidco and Edwards already are the go to cardiac monitoring devices.The point is whether things stay that way - the former has no positive randomised control result after multiple attempts, the latter has little evidence to back it either.This appears to matter little to the NHS, which probably goes a long way toward understanding the mess it is in. It is neither underfunded or overly stretched, just very badly managed.|
|Deltex has significant debts and falling UK sales. It has given up on greater UK success and has switched its focus to the US. Will this work?I think Lidco and Edwards LifeSciences will displace it as the go to cardiac output monitoring modalities.Time to sell.|
|Why would you expect the total to be achieved by now? The distribution of announcement times is fairly random, and in terms of the cumulative totals, I don't see any evidence of a drop off.
Last 22 US Accounts:
|Agreed. Still, better a little and late than nothing.|
|An underwhelming reaction to an underwhelming RNS, I was expecting to hear that the target of 30 platform accounts had been reached by now (albeit two months late).|
|I have 400,000 average 10p each, I am going to hang in there and see what happens.|
|Really believe that the technology would vastly improve patient care in the NHS and around the world. However, having lost over 70% am thinking to take what little is left and try to recoup or do I hang on hoping for the golden egg or a takeover??|
|How can they possibly avoid having to fund raise?
Sorry to say it looks like more dilution unless they can find a buyer or get very, very lucky.
Great product needing cash injection.|
|I've bought a few, but it still leaves my average price a depressing 17p. The signs are strong that DEMG are trying to raise more money, but I live in hope.|
|I did hear that a massive SELLING opportunity was once staring an amateur investor in the face, and the amateur investor totally failed to take advantage of it. The selling opportunity passed.
Heaven forbid that anything like that would happen to me. Oh, no.|
|I've had many of those of many many years!|
|It's a buying opportunity! Hooray! Hooray!!!|
|Oh dear oh dear all the way up and back again! This is a tedious business that makes watching grass grow more interesting! What's up now? Anyone?|
|When the worst happens, it's important to be completely paralytic.
|Ok, you asked for it:
|Beware of the Orange Goblin.
Beauty is only skin deep, but ugly goes clean to the bone.|
|There are lots of crackers rushing around, especially a short distance West of here. Tomorrow will be International Crackers Day.
Let us not forget that there are other snacks, such as crisps, twiglets and nuts. Ergo, tomorrow can also be International Nuts Day.
It is, by coincidence, the day of knocking on doors, colloquially known as bonking. Tomorrow will therefore be International Bonkers Day.
Tomorrow is also the day of games with small balls, and the commiseration of trivial disasters, such as losing said balls. Accordinagly, tomorrow can also be referred to as International I’VE LOST MY MARBLES! I’VE LOST MY MARBLES! I’VE LOST MY MARBLES! I’VE LOST MY MARBLES! I’VE LOST MY MARBLES! I’VE LOST MY MARBLES! I’VE LOST MY MARBLES! Day.|
|I reckon financing already done. 10m shares at 4p £400,000|
|fwiw I don't think Deltex were overly optimistic, certainly not in comparison to investors. Everything seemed to be in place with NICE and the NHS pace and scale stuff.
Perhaps it needed a few more people who have actually been through the process of getting stuff sold into the NHS, to say don't count any chickens at all for a few years, given the history of getting stuff into the NHS. But I certainly didn't want to be told that.|
|I think its good news that ODM has kicked out a competitor's technology....there's a message to the NHS|
|"A 450 bed NHS hospital in the South-East of England has acquired six CardioQ-ODM+ monitors and an initial stock of single patient oesophageal probes for use in its peri-operative surgical care. The hospital invested in ODM in response to clinician demand to replace the alternative technology purchased by the Trust as a result of the 2013 NHS national implementation programme for Intra-Operative Fluid Management. The initial order was worth over GBP30,000 and although this does not alter full year forecasts, it does reflect a generally improving UK performance in the second half of the year to date."
Is this not strange wording? ......... "HAS ACQUIRED"
It doesn't seem to say specifically that this was part of the order.
Have the six CardioQ-ODM+ been TRANSFERRED from another body e.d NHS Purchased stock?
The probes, however,have clearly been ordered.
Still good news on the home front ... at last!|
|The good thing about the Spanish study was that it was multi centre and funded by their government.
Deltex should be congratulated in capturing a customer from presumably LID. Well done. Lets hope there are more to come!|
|Sorry folks, in my rush today i did miss: ' it does reflect a generally improving UK performance in the second half of the year to date.'
--> Lets hope we have hit bottom re the UK market and are now on the long march upwards....hopefully with big orders by January / Feb 2017. As March 2017 might be squeezed due to the end of the NHS's financial year on the 31/3/17 and NHS cash gets a bit tight.|